Financials
- Financial year
- 2025
- Total assets
- €197,974
- Profit
- €65,312
- Solvency
- 81.9%
Total assets▲ 53.0%
Net result
20242025
MEDIDEV
ActiveSummary
MEDIDEV has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €162,199 and a net result of €65,312. The computed 12-month bankruptcy probability is 0.5% (very low).
Overview
Activity
“De uitoefening van de geneeskunst, met inbegrip van de gespecialiseerde geneeskunde of enige aanverwante…” (deed in Dutch)
From the articles, 13 activitiesNo NACE code in the KBO yet1 site
Size
≈ €260,000turnover 2025, estimated
- Equity
- €162,199
- Profit
- €65,312
Turnover estimated from the gross margin
Why 87raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 5.48, cash €154,350Size: total assets €197,974Figures for financial year 2025 (filed 30-06-2026)Show the evidence
Checked score
Score 2025
87
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 86% of its sector peers (no NACE code, micro)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 81.9% of total assets
Liquidity
95+4
short-term debt 18.0% · cash 78.0%
Profitability
100=
return on assets 33.0%
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
05-2025: 2.4%
06-2025: 2.5%▲ +0.1 percentage points vs 05-2025
07-2025: 2.5%● unchanged vs 06-2025highest value
08-2025: 0.1%▼ -2.4 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025lowest value
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.2%▲ +0.1 percentage points vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.1%▼ -0.1 percentage points vs 03-2026
05-2026: 0.2%▲ +0.1 percentage points vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.3%▲ +0.1 percentage points vs 06-2026
08-2026: 1.5%▲ +1.2 percentage points vs 07-2026
09-2026: 1.6%▲ +0.1 percentage points vs 08-2026
10-2026: 0.5%▼ -1.1 percentage points vs 09-2026
Credit of up to €14,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 5.48, compared with 3.98 in 2024, above the usual 1.5; short-term debt: 18% and cash: 78% of total assets), and 18.1% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 86% on liquidity, 90% on profitability and 89% on growth.
The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
31 days early
2024
21 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 2 accounts on average 26 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
- Amendment of the articles · Name…Capital · Registered office clause…
- Registered office · MiscellaneousRegistered-office move · Registered office…
- Annual accounts filedfinancial year 2025 · micro…
Key points
By topic
Board & ownership
- Board
- 1 member
- DEVILLET Valentine Josette NinonDirector
Timeline
- Events
- 6
- Since
- 2024
- Next accounts
- by 31-07-2027
- 31-12-2025Equity above €150,000
- 10-07-2025Annual accounts filed
- 10-04-2024Incorporation
Company details
- Sites
- 1
- Legal form
- Private limited company
- Founded
- 08-04-2024
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 40
- Who signs
- Each director alone
- Annual meeting
- Last Friday of June at 19:00
- Purpose
- “De uitoefening van de geneeskunst, met inbegrip van de gespecialiseerde geneeskunde of…” (deed in Dutch)
- Statutory auditor
- No statutory auditor
Key facts about MEDIDEV
- What is the company number of MEDIDEV?
- 1008.121.493. In Belgium the VAT number is the company number with BE in front: BE 1008.121.493.
- Where is MEDIDEV based?
- The registered office is at Alsembergsesteenweg 77, 1630 Linkebeek.Company details
- What is the legal form of MEDIDEV?
- Private limited company (BV).
- When was MEDIDEV founded?
- On 08-04-2024.
- Is MEDIDEV still active?
- Yes, MEDIDEV is an active enterprise in the KBO register.
- What is the turnover of MEDIDEV?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is MEDIDEV profitable?
- In financial year 2025, MEDIDEV made a profit of €65,312.
- Where can I find the annual accounts of MEDIDEV?
- MEDIDEV filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDIDEV due?
- By 31-07-2027, for financial year 2026.Timeline
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.